Vanguard Group Inc Pardes Biosciences, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.4 - $1.95 $196,772 - $274,076	-140,552 Reduced 12.38%	994,997 $1.8 Million
Q1 2023 May 15, 2023	BUY	$1.21 - $2.22 $6,483 - $11,894	5,358 Added 0.47%	1,135,549 $1.5 Million
Q4 2022 Feb 10, 2023	BUY	$0.85 - $1.69 $5,383 - $10,702	6,333 Added 0.56%	1,130,191 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$2.14 - $3.7 $46,703 - $80,748	21,824 Added 1.98%	1,123,858 $2.08 Million
Q2 2022 Aug 12, 2022	BUY	$2.84 - $8.57 $329,610 - $994,634	116,060 Added 11.77%	1,102,034 $3.38 Million
Q1 2022 May 13, 2022	BUY	$5.64 - $15.64 $5.56 Million - $15.4 Million	985,974 New	985,974 $7.12 Million

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.